Market Tracker

05/25 5:16pm ET

VIVUS Inc (NASDAQ:VVUS)

1.12
Delayed Data
As of 3:59pm ET
 +0.02 / +1.82%
Today’s Change
0.93
Today|||52-Week Range
1.47
-2.61%
Year-to-Date
Aerie's Ophthalmic Candidate Positive in Registration Trial
3:02pm / Zacks.com - Paid Partner Content
Novartis (NVS) Reports Positive Data on Ultibro Breezhaler
7:51am / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Gets Priority Review for Liver Cancer
11:20am / Zacks.com - Paid Partner Content
Achaogen's Plazomicin Gets Breakthrough Therapy Designation
May 24 / Zacks.com - Paid Partner Content
Regeneron Presents Positive Phase II Data on HoFH Candidate
11:03am / Zacks.com - Paid Partner Content
Theravance/Mylan Presents Phase III Data on COPD Candidate
May 24 / Zacks.com - Paid Partner Content
Puma Biotechnology (PBYI) Jumps: Stock Adds 29.7% in Session
8:51am / Zacks.com - Paid Partner Content
5 Reasons Why VIVUS (VVUS) Stock Should Be in Your Portfolio
May 24 / Zacks.com - Paid Partner Content
Horizon (HZNP) Sells European Rights for Procysbi & Quinsair
8:01am / Zacks.com - Paid Partner Content
Ultragenyx Receives Priority Review for rhGUS from FDA
May 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.10
Today’s open1.13
Day’s range1.10 - 1.13
Volume802,920
Average volume (3 months)616,784
Market cap$118.4M
Dividend yield--
Data as of 3:59pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-277.27%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratio3.4
Price/Sales0.97
Price/Book6.46

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...-0.24-2.86%
VTLVital Therapies Inc-0.38-11.72%
GEMPGemphire Therapeutic...+0.11+1.10%
CPIXCumberland Pharmaceu...-0.06-0.85%
Data as of 3:59pm ET, 05/25/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts